$11.65+0.02 (+0.17%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Aveanna Healthcare Holdings (AVAH) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~9.7%/yr (FY21→FY25), net margin 9.2%; free cash flow runs at 53% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+16.4%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲20.2%
2,433.2
FY21→FY25CAGR +9.7%/yr
Net income ($M)—
225.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▲349.9%
118.4
FY21→FY25CAGR —
Diluted EPS—
1.05
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+16.4%
184.7mn → 215.0mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$7.4M
+17.8% YoY in FY25 · 0.3% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
9¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 32.3% → 33.3%. Net margin 9.2% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,676.4 | 2,433.2 | 2,024.5 | 1,895.2 | 1,787.6 | 1,678.6 | ▲20.2% | +9.7% |
Cost of revenue | 1,812.4 | 1,622.7 | 1,389.0 | 1,299.8 | 1,234.4 | 1,136.2 | ▲16.8% | +9.3% |
Gross profit | 864.0 | 810.5 | 635.5 | 595.4 | 553.2 | 542.4 | ▲27.5% | +10.6% |
Selling, general & admin | 394.0 | 374.5 | 352.8 | 361.0 | 357.2 | 297.4 | ▲6.1% | +5.9% |
Total operating expenses | 560.1 | 554.0 | 495.8 | 587.4 | 1,195.5 | 578.5 | ▲11.8% | −1.1% |
Operating incomefeeds ROC rank | 303.9 | 256.5 | 139.8 | 8.1 | −642.3 | −36.1 | ▲83.5% | — |
Other income, net | −98.4 | −149.5 | −134.7 | −147.1 | −21.5 | −77.5 | — | — |
Pretax income | 205.5 | 106.9 | 5.1 | −139.0 | −663.8 | −113.6 | ▲2008.6% | — |
Income tax | −100.7 | −118.1 | 16.0 | −4.5 | −1.8 | 3.5 | — | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 306.1 | 225.0 | −10.9 | −134.5 | −662.0 | −117.0 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 1.40 | 1.05 | −0.06 | −0.71 | −3.57 | −0.69 | — | — |
Diluted shares (mn) | 229.22 | 214.98 | 192.89 | 189.96 | 185.55 | 184.73 | ▲11.4% | +3.9% |
| Margins | ||||||||
Gross margin14th pct in Healthcare | 32.3% | 33.3% | 31.4% | 31.4% | 30.9% | 32.3% | ▲1.9pp | +1.0pp |
Operating margin | 11.4% | 10.5% | 6.9% | 0.4% | −35.9% | −2.2% | ▲3.6pp | +12.7pp |
Net margin71st pct in Healthcare | 11.4% | 9.2% | −0.5% | −7.1% | −37.0% | −7.0% | ▲9.8pp | +16.2pp |
† TTM = trailing four quarters through 2026-10-03.FY24 effective tax rate was 315% vs a 0% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was −110% vs a 0% norm for this window, likely a one-time item; see the filing.
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Aveanna Healthcare Holdings' revenue last fiscal year?
Aveanna Healthcare Holdings reported revenue of $2,433.2M in fiscal 2025, up 20.2% from fiscal 2024.
What was Aveanna Healthcare Holdings' net income?
Aveanna Healthcare Holdings reported net income of $225.0M in fiscal 2025, a net margin of 9.2%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

